Latest News and Press Releases
Want to stay updated on the latest news?
-
Optimi’s 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression.The export marks Optimi’s third commercial shipment since launching the 5mg psilocybin capsules in...
-
LOUISVILLE, Ky., June 29, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “we,” “us,” “our,” or the “Company”), a leading provider of digital signage, media and AdTech...
-
SailPoint today announced it has completed its acquisition of Tel Aviv-based Entro Security.
-
SANTA MARIA, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- AMASS Brands Group (NASDAQ: AMSS) (“AMASS” or “the Company”), a premium, multi-category beverage platform spanning non-alcohol, functional, and...
-
First-in-Human Results Demonstrate Favorable Safety and Pharmacokinetics Profile AI Aided Target Engagement Research Advancing Development of Novel Biomarkers SOLANA BEACH, Calif., June 29, 2026 ...
-
TAMPA, Fla. and LONDON, June 29, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing...
-
Raanana, Israel, June 29, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative...
-
NEW YORK, June 29, 2026 (GLOBE NEWSWIRE) -- RoboStrategy, Inc. (Nasdaq: BOT) (“RoboStrategy” or the “Fund”), a registered closed end fund providing exposure to private companies in robotics and...
-
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study
-
Playboy Joins Small-Cap Russell 2000® Index and Broad-Market Russell 3000® Index